MicroPoint Bioscience Inc (MBI) is a leading provider of microfluidic devices and systems for medical and biomedical applications. It is dedicated to the research, development, manufacturing, and marketing of the "Lab-On-Chip"products based on the MEMS (Micro-Electro-Mechanical System) technology. It provides customized products and cost effective solutions for various clients in life science and health related applications such as medical diagnostics, environmental protection, food safety and bio-medical research.
In the medical diagnostic field, MBI's Point-Of-Care (POC) diagnostic devices and microfluidic cartridges provide fast, efficient, safe, accurate, and low-cost solutions for the early diagnosis and monitoring of cardiovascular diseases and tumors. With the introduction of the innovative POC diagnostic system, mLabs TM , MBI provides the end-users a flexible common platform for the in-vitro diagnostics conducted in the emergency rooms, at the patient's bedside, and in physician's offices. mLabs TM based technologies have been patented in US, Europe and China
Founded in 2006, MicroPoint Bioscience Inc. is headquartered in Santa Clara, CA. MBI's China headquarter is located in Shenzhen, a fast growing metropolitan region neighboring Hong Kong in southern China . MBI also has a branch office in Beijing , China .